CN Patent

CN1980909B — 作为激酶抑制剂的2-氨基噻唑-5-芳香族甲酰胺的制备方法

Assigned to Bristol Myers Squibb Co · Expires 2010-08-25 · 16y expired

What this patent protects

本发明涉及制备具有式(I)的化合物及其结晶形式的方法，其中Ar是芳基或杂芳基，L是任选的亚烷基连接基，以及R 2 、R 3 、R 4 和R 5 如本说明书中定义，其中所述的化合物用作激酶抑制剂，特别是用作蛋白酪氨酸激酶和p38激酶的抑制剂。

USPTO Abstract

本发明涉及制备具有式(I)的化合物及其结晶形式的方法，其中Ar是芳基或杂芳基，L是任选的亚烷基连接基，以及R 2 、R 3 、R 4 和R 5 如本说明书中定义，其中所述的化合物用作激酶抑制剂，特别是用作蛋白酪氨酸激酶和p38激酶的抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN1980909B
Jurisdiction
CN
Classification
—
Expires
2010-08-25
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.